HB0034

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HB0034, covering 2025-01-20 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) [Phase 2]